An injectable biomaterial activated by pulses of low-energy blue light has tremendous potential for on-the-spot repair to the domed outer layer of the eye, a team of University of Ottawa researchers and their collaborators have revealed.
Grail CEO predicts ‘transformative’ 2024 amid Illumina split
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Grail has detailed its goals